The Scientist

» human evolution, culture and immunology

Most Recent

image: Contributors

Contributors

By | June 1, 2016

Meet some of the people featured in the June 2016 issue of The Scientist.

0 Comments

image: Enhancing Vaccine Development

Enhancing Vaccine Development

By | June 1, 2016

Using proteomics methods to inform antigen selection

1 Comment

image: Hot Off the Presses

Hot Off the Presses

By | June 1, 2016

Beyond Biocentrism, The Sting of the Wild, The Birth of Anthropocene, and Ordinarily Well

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | June 1, 2016

14-day-old embryos, prioritizing biodiversity, and more

0 Comments

image: Start Making Sense

Start Making Sense

By | June 1, 2016

Scientific progress is only achieved when humans' innate sense of understanding is validated by objective reality.

6 Comments

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

image: Toward Targeted Therapies for Autoimmune Disorders

Toward Targeted Therapies for Autoimmune Disorders

By | June 1, 2016

Training the immune system to cease fire on native tissues could improve outcomes for autoimmune patients, but clinical progress has been slow.

2 Comments

image: FDA Approves Bladder Cancer Immunotherapy

FDA Approves Bladder Cancer Immunotherapy

By | May 23, 2016

The US Food and Drug Administration greenlights Roche’s Tecentriq, which blocks a protein that obstructs the immune system’s ability to fight cancer.

0 Comments

Certain drugs could worsen graft-versus-host disease in stem cell transplant patients, scientists show.

1 Comment

image: Tasmanian Devil Antibodies Fight Cancer

Tasmanian Devil Antibodies Fight Cancer

By | May 9, 2016

The proteins could be the key to stopping the transmissible facial tumor disease that is threatening the species.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech